17 records matched your query
05635aam a2200505 i 4500 001 A94D4B48FAD211E7A45C351A97128E48 003 SILO 005 20180116092551 008 141106s2015 nyua b 001 0 eng 010 $a 2014043946 020 $a 1621820831 020 $a 9781621820833 035 $a (OCoLC)894816613 040 $a DLC $b eng $e rda $c DLC $d YDX $d BDX $d YDXCP $d BTCTA $d OCLCF $d CDX $d CHVBK $d OCLCO $d UtOrBLW $d SILO 042 $a pcc 050 00 $a K1519.B54 $b I56 2015 $0 http://id.loc.gov/authorities/classification/K 060 4 $a QU 33.1 082 00 $a 346.04/86 $2 23 084 $a MED022000 $a MED107000 $a MED022000 $2 bisacsh 245 00 $a Intellectual property in molecular medicine / $c edited by Salim Mamajiwalla, In(sci)te IP, Inc.; Rochelle Seide, R. Seide Consulting, LLC. 264 1 $a Cold Spring Harbor, New York : $b Cold Spring Harbor Laboratory Press, $c [2015] 300 $a ix, 289 pages : $b color illustrations ; $c 26 cm 500 $a "A subject collection from Cold Spring Harbor perspectives in medicine." 520 $a "As universities increasingly spin off biotech companies and academics work more closely with these companies and the pharma industry, it is essential that they gain an understanding of intellectual property law and patenting. This book introduces the basic ideas and discusses how they apply to biomedical research and product development in the age of genomics"-- $c Provided by publisher. 504 $a Includes bibliographical references and index. 505 0 $a Machine generated contents note: -- (preliminary) -- 1. Introduction to Intellectual Property: A US Perspective -- Amanda Murphy, Michael Stramiello, Tom Irving, and Stacy Lewis -- 2. Impact of America Invents Act on Biotech Intellectual Property -- Amanda Murphy, Michael Stramiello, Tom Irving, and Stacy Lewis -- 3. Patenting the Life Sciences at the European Patent Office -- Christina Gates -- 4. The Role of Regulatory Agencies and Intellectual Property -- Kevin Noonan -- 5. Regulatory Law and Intellectual Property in Europe -- Anne Bateman -- 6. Canada's Patented Medicines (Notice of Compliance) Proceedings and Intellectual Property -- Henry Bian and Conor McCourt -- 7. Inventorship and Authorship -- Antoinette F. Konski -- 8. Must an Inventor "Possess" an Invention to Patent It? -- Warren D. Woessner and Robin A. Chadwick. 505 0 $a 9. What is Your Reasonable Expectation of Success in Obtaining Pharmaceutical or Biotechnology Patents Having Non-Obvious Claimed Inventions that Will courts Will Uphold? An Overview of Obviousness Court Decisions -- Daniel Pereira and Stephen G. Kunin -- 10. Inherent Anticipation in Pharma and Biotech -- Michael Goldman, Georgia Evans, and Andrew Zappia -- 11. Baseball Bats and Chocolate Chip Cookies: The Judicial Treatment of DNA in the Myriad Genetics Litigation -- Ian Binnie and Vanessa Park-Thompson -- 12. Patentability of Genes: An EU Perspective -- Paul Cole -- 13. Decoding Gene Patents in Australia -- Adam Denley and James Cherry -- 14. The Impact of Myriad and Mayo: Will Advancements in the Biological Sciences be Spurred or Disincentivized? (Or, Wasn't Biotech Patenting Complicated Enough?) -- Jennifer Gordon -- 15. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics -- Michele Wales. 505 0 $a 16. Research Use Exemptions to Patent Infringement for Drug Discovery and Development in the United States -- Alicia A. Russo and Jason Johnson -- 17. Research Exemption / Experimental Use in the EU: Patents Do Not Block the Progression of Science -- Hans-Rainer Jaenichen and Johann Pitz -- 18. Patenting Stem Cell Technologies in the US -- Donald L. Zuhn -- 19. Patenting Stem Cell Technologies in Europe -- Andrew Sheard -- 20. The Patentability of Stem Cells in Australia -- Jenny Petering and Prue Cowin -- 21. Patentability of Self-Replicating Technologies -- Richard H. Shear -- 22. Protecting Traditional Knowledge Related to Biological Resources: Is Scientific Research Going to Become More Bureaucratized? -- Prashant Reddy and Malathi Lakshmikumaran -- 23. Licensing Biotech IP in University Industry Partnerships -- Vladimir Drozdoff and Daryl Fairbairn -- 24. Trade Secrets in Life Science and Pharmaceutical Companies -- Tara Nealey, Ronald M. Daignault, and Yu Cai -- 25. Trade Secrets in Canada -- Noel Courage and janice Calzavara. 650 0 $a Biotechnology $v Patents. $0 http://id.loc.gov/authorities/subjects/sh2008000341 650 0 $a Intellectual property. $0 http://id.loc.gov/authorities/subjects/sh85067167 650 0 $a Molecular biology. $0 http://id.loc.gov/authorities/subjects/sh85086577 650 7 $a SCIENCE / Life Sciences / Genetics & Genomics. $2 bisacsh 650 7 $a MEDICAL / Genetics. $2 bisacsh 650 7 $a MEDICAL / Diseases. $2 bisacsh 650 7 $a Biotechnology $x Patents. $2 fast $0 (OCoLC)fst00832761 650 7 $a Intellectual property. $2 fast $0 (OCoLC)fst00975774 650 7 $a Molecular biology. $2 fast $0 (OCoLC)fst01024734 650 2 $a Molecular Medicine $x legislation & jurisprudence. $0 https://id.nlm.nih.gov/mesh/D062346Q000331 650 2 $a Patents as Topic. $0 https://id.nlm.nih.gov/mesh/D010330 650 2 $a Genetics, Medical $x legislation & jurisprudence. $0 https://id.nlm.nih.gov/mesh/D005826Q000331 700 1 $a Mamajiwalla, Salim, $e editor. $0 http://id.loc.gov/authorities/names/no2013101959 700 1 $a Seide, Rochelle K., $e editor. $0 http://id.loc.gov/authorities/names/no2002115037 941 $a 1 952 $l OVUX522 $d 20191211024435.0 956 $a http://locator.silo.lib.ia.us/search.cgi?index_0=id&term_0=A94D4B48FAD211E7A45C351A97128E48Initiate Another SILO Locator Search